Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.
Tumor Pathology Department, Maria Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.
Int J Mol Sci. 2018 Sep 6;19(9):2647. doi: 10.3390/ijms19092647.
promoter (p) mutations are important factors in papillary thyroid carcinomas (PTCs). They are associated with tumor aggressiveness, recurrence, and disease-specific mortality and their use in risk stratification of PTC patients has been proposed. In this study we investigated the prevalence of p mutations in a cohort of Polish patients with PTCs and the association of these mutations with histopathological factors, particularly in coexistence with the V600E mutation. A total of 189 consecutive PTC specimens with known mutational status were evaluated. p mutations were detected in 8.5% of cases (16/189) with the C228T mutation being the most frequent. In six of the PTC specimens (3.2%), four additional p alterations were found, which included one known polymorphism (rs2735943) and three previously unreported alterations. The association analysis revealed that the p hotspot mutations were highly correlated with the presence of the V600E mutation and their coexistence was significantly associated with gender, advanced patient age, advanced disease stage, presence of lymph node metastases, larger tumor size, and tumor-capsule infiltration. While correlations were identified, the possibility of p mutations being key molecular modulators responsible for PTC aggressiveness requires further studies.
启动子 (p) 突变是甲状腺乳头状癌 (PTC) 的重要因素。它们与肿瘤侵袭性、复发和疾病特异性死亡率相关,因此被提议用于 PTC 患者的风险分层。在这项研究中,我们调查了波兰一组 PTC 患者中 p 突变的流行情况,以及这些突变与组织病理学因素的关联,特别是与 V600E 突变的共存情况。总共评估了 189 例已知突变状态的连续 PTC 标本。在 8.5%的病例 (16/189) 中检测到 p 突变,其中 C228T 突变最为常见。在 6 例 PTC 标本 (3.2%) 中发现了另外 4 个 p 改变,包括一个已知的多态性 (rs2735943) 和 3 个以前未报道的改变。关联分析表明,p 热点突变与 V600E 突变的存在高度相关,它们的共存与性别、患者年龄较大、疾病分期较晚、存在淋巴结转移、肿瘤较大和肿瘤包膜浸润显著相关。虽然存在相关性,但 p 突变是否是导致 PTC 侵袭性的关键分子调节剂仍需要进一步研究。